| Literature DB >> 35009019 |
Fatima Zahrae Radi1, Mohamed Bouhrim1, Hamza Mechchate2, Mohammed Al-Zahrani3, Ashraf Ahmed Qurtam3, Abdulmalik M Aleissa4, Aziz Drioiche1, Nadia Handaq1, Touriya Zair1.
Abstract
Essential oils (EOs) are chemical products produced by odoriferous glands from a variety of plants. These essential oils have many health benefits: antiseptic, anti-inflammatory and antimicrobial activities. So due to these medicinal properties, the present study was designed to analyze essential oils of Thymus zygis L. and Thymus willdenowii Boiss. for their chemical composition and biological activities. These two thyme species were collected from the region of Ifrane, Middle Atlas of Morocco. The EO was obtained by hydrodistillation, and the yields were 5.25% for T. zygis and 3.00% for T. willdenowii. The chemical composition of the EOs was analyzed by gas chromatography coupled with mass spectrometry (GC-MS), and the results showed that T. zygis EO is dominated by carvacrol (52.5%), o-cymene (23.14%), and thymol (9.68%), while the EO of T. willdenowii contains germacrene D (16.51%), carvacrol (16.19%), and geranyl acetate (8.35%) as major compounds. The antioxidant activity assessed by Diphenylpicrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assays revealed that both EOs have excellent antioxidant activities; by DPPH it resulted in IC50 = 6.13 ± 0.11 for T. zygis and 6.78 ± 0.3 µg/mL for T. willdenowii, while the one by FRAP yielded EC50 = 2.46 ± 0.01 (T. zygis) and 5.17 ± 0.2 (T. willdenowii) µg/mL. The antimicrobial activity of the two essential oils was evaluated against six bacterial strains and five fungal strains by the disk diffusion method to determine the Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC). The EOs revealed variable antimicrobial activities against the different tested microbial strains and showed strong antimicrobial activities, even against strains known as multi-resistant to antibiotics (Acinetobacter baumannii) at low concentrations (2 µL/mL). T. zygis EO showed the most powerful activity against all the studied bacteria, while that of T. willdenowii recorded moderate activity when tested against Shigella dysenteriae and Salmonella Typhi. With inhibition diameters that vary between 75 mm and 84 mm for concentrations of 2 µL/mL up to 12 µL/mL, S. aureus was shown to be the most sensitive to T. zygis EO. For the antifungal activity test, T. zygis EO showed the best inhibition diameters compared to T. willdenowii EO. These results showed that T. zygis EO has more powerful antioxidant and antimicrobial activities than T. willdenowii EO, therefore, we deduce that thyme EOs are excellent antioxidants, they have strong antimicrobial properties, and may in the future represent new sources of natural antiseptics that can be used in pharmaceutical and food industry.Entities:
Keywords: GC-MS analysis; Thymus willdenowii Boiss; Thymus zygis L.; bacteria; fungi; molds; multi-resistant bacteria; volatile compounds
Year: 2021 PMID: 35009019 PMCID: PMC8747066 DOI: 10.3390/plants11010015
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
The Eos yields of the two selected thyme species.
| Harvest Site | EO | Yield (%) |
|---|---|---|
| Azrou |
| 5.25 ± 0.01 |
| Ifrane |
| 3.00 ± 0.02 |
Refractive index, degree Brix, and essential oils density of T. zygis and T. willdenowii.
|
|
| |
|---|---|---|
| Density | 0.92 ± 0.05 | 0.91 ± 0.05 |
| Refractive index | 1.50 ± 0.05 | 1.33 ± 0.04 |
| Degree degree (%) | 85.44 ± 0.05 | 76.62 ± 0.05 |
Figure 1Chromatograms of the EOs. (A) T. zygis, (B) T. willdenowii.
Chemical composition of the thymes EOs.
| No. | Compounds | Kováts Index (KI) | Molecular Formula | Area% | |
|---|---|---|---|---|---|
|
|
| ||||
| 1 | 939 | C10H16 | 0.59 | 0.62 | |
| 2 | Camphene | 954 | C10H16 | 0.96 | 0.78 |
| 3 | β-Pinene | 979 | C10H16 | - | 0.06 |
| 4 | 1-Octen-3-ol | 979 | C8H16O | - | 0.20 |
| 5 | Myrcene | 990 | C10H16 | 2.43 | 0.27 |
| 6 | 3-δ-Carene | 1002 | C10H16 | - | 0.29 |
| 7 | 1024 | C10H14 | 1.78 | - | |
| 8 | 1026 | C10H14 | - | 23.14 | |
| 9 | Limonene | 1029 | C10H16 | 2.16 | 0.28 |
| 10 | 1,8-Cineole | 1031 | C10H18O | 1.77 | 0.18 |
| 11 | 1037 | C10H16 | 0.42 | - | |
| 12 | 1059 | C10H16 | 0.61 | 1.98 | |
| 13 | 1072 | C10H18O2 | - | 0.13 | |
| 14 | 1086 | C10H18O2 | - | 0.25 | |
| 15 | Linalool | 1096 | C10H18O2 | 1.78 | 2.40 |
| 16 | Camphor | 1146 | C10H16O2 | 5.99 | 0.16 |
| 17 | Borneol | 1169 | C10H18O | 4.74 | 3.30 |
| 18 | Terpinen-4-ol | 1177 | C10H18O | 1.06 | 0.35 |
| 19 | α-Terpineol | 1188 | C10H18O | - | 0.10 |
| 20 | Pulegone | 1237 | C10H16O | - | 0.08 |
| 21 | Carvacrol methyl ether | 1244 | C10H16O | - | 0.07 |
| 22 | Thymol | 1290 | C10H14O | 1.28 | 9.68 |
| 23 | Carvacrol | 1299 | C10H14O | 16.19 | 52.2 |
| 24 | Geranyl acetate | 1381 | C12H20O2 | 8.35 | - |
| 25 | β-Bourbonene | 1388 | C15H24 | 2.48 | - |
| 26 | β-Elemene | 1390 | C15H24 | 3.96 | - |
| 27 | ( | 1419 | C15H24 | 5.59 | 0.99 |
| 28 | β-YLangene | 1420 | C15H24 | 0.51 | - |
| 29 | γ-Elemene | 1436 | C15H24 | 0.82 | - |
| 30 | Germacrene D | 1481 | C15H24 | 16.51 | - |
| 31 | α-Murolene | 1500 | C15H24 | - | 0.09 |
| 32 | γ-Amorphene | 1512 | C15H24 | 0.87 | 0.07 |
| 33 | γ-Cadinene | 1513 | C15H24 | 0.87 | - |
| 34 | Spathulenol | 1578 | C15H24O | 0.96 | 0.18 |
| 35 | Caryophyllene oxide | 1583 | C15H24O | 6.90 | 1.06 |
| 36 | 1640 | C15H24O | 0.92 | - | |
| 37 | Caryophylla-4(12),8(13)-dien-5β-ol | 1640 | C15H24O | - | 0.09 |
| 38 | 1640 | C15H26O | - | 0.09 | |
| 39 | Cubenol | 1646 | C15H26O | 0.55 | - |
| 40 | Eudesmol | 1650 | C15H26O | 0.61 | - |
| 41 | Cedr-8(15)-en-10-ol | 1652 | C15H24O | - | 0.20 |
| 42 | α-Cadinol | 1654 | C15H18 | 1.32 | - |
| 43 | Cadalene | 1676 | C15H18 | - | 0.23 |
| 44 | Germacra-4(15),5,10(14)-trien-1α-ol | 1686 | C15H24O | 2.09 | - |
| 45 | hexahydrofarnesyl acetone | 1932 | C18H36O | 0.62 | - |
| 46 | Cembrene C | 1940 | C20H18 | 0.69 | - |
| 47 | Hexadecanoic acid | 1960 | C16H32O2 | 2.31 | - |
| 48 | 2208 | C21H32O | - | 0.07 | |
| Oxygenated monoterpenes | 32.81 | 68.7 | |||
| Hydrocarbon monoterpenes | 8.95 | 27.55 | |||
| Hydrocarboned sesquiterpene | 31.61 | 1.4 | |||
| Oxygenated sesquiterpene | 13.35 | 1.85 | |||
| Lignar esters | 8.35 | - | |||
| Others | 3.62 | 0.27 | |||
| Total | 98.69 | 99.84 | |||
Figure 2Percentage of chemical families in the thymes EO.
Figure 3DPPH Free radical scavenging activity of T. zygis, T. willdenowii, and ascorbic acid. Inhibitory percentage (A) and IC50 (B) against the DPPH Free radical. data are presented as mean ± SD, the experiment was performed in a minimum of 2 replicates T. zygis: Thymus zygis, T. willdenowii: Thymus willdenowii.
Figure 4The effective concentrations (EC50) of T. zygis, T. willdenowii and ascorbic acid; data are mean ± SD, experiment was performed in minimum 2 replicates T. zygis: Thymus zygis, T. willdenowii: Thymus willdenowii.
Antibiotic sensitivity test for A. baumannii and E. cloacae.
| ATB |
| ATB |
|
|---|---|---|---|
| TIC75 | 6 ± 00 (R) | TIC75 | 6 ± 00 (R) |
| CAZ30 | 6 ± 00 (R) | CAZ30 | 20 ± 00 (S) |
| MEM10 | 6 ± 00 (R) | OFX5 | 6 ± 00 (R) |
| TIM85 | 6 ± 00 (R) | AMC3 | 6 ± 00 (R) |
| IPM10 | 6 ± 00 (R) | IPM10 | 27 ± 0.1 (S) |
| CT50 | 6 ± 00 (R) | CT50 | 6 ± 00 (R) |
| TOB10 | 6 ± 00 (R) | FOX30 | 21 ± 00 (S) |
| CIP5 | 6 ± 00 (R) | AML10 | 6 ± 00 (R) |
| TE30 | 6 ± 00 (R) | CN15 | 22 ± 0.2 (S) |
| CN15 | 21.5 ± 0.1 (S) | AK30 | 19 ± 00 (I) |
| AK30 | 6 ± 00 (R) | ||
| PRL75 | 6 ± 00 (R) |
S: sensitive at standard dose, R: resistant, ATB: antibiotics, TOB: Tobramycin, TIC: Ticarcillin, AML: Amoxicillin, FOX: Cefoxitin, CT: Colistin, CIP: Ciprofloxacin, AK: Amikacin, IPM: Imipenem, CAZ: Ceftazidime, PRL: Piperacillin, TE: Tetracycline, CN: Cefalexin, MEM: Meropenem, TIM: Ticarcillin + Clavulanic acid, OFX: Ofloxacin, Antibiotic disc load was in µg.
Antibiotic sensitivity test for S. aureus, E. coli, S. Typhi, and S. dysenteriae.
| ATB |
| ATB |
|
| |
|---|---|---|---|---|---|
| CIP5 | 23 ± 0.1 (S) | CT50 | 20 ± 0.1 (S) | 20 ± 0.1 (S) | 21 ± 0.2 (S) |
| VA30 | 26 ± 0.3 (S) | MEM10 | 21 ± 0.2 (S) | 22 ± 0.2 (S) | 23.5 ± 0.1 (S) |
| TE30 | 24.5 ± 0.2 (S) | TIC75 | 06 ± 00 (R) | 21.5 ± 00 (S) | 20.5 ± 0.3 (S) |
| CN15 | 21 ± 0.1 (S) | AK30 | 20 ± 0.1 (S) | 22 ± 0.2 (S) | 22 ± 0.1 (S) |
| MY15 | 30 ± 0.1 (S) | C30 | 27 ± 00 (S) | 29 ± 00 (S) | 20 ± 00 (S) |
| E15 | 20 ± 00 (S) | PRL75 | 21 ± 00 (S) | 21 ± 00 (S) | 21 ± 00 (S) |
| CAZ30 | 22 ± 0.3 (S) | IPM10 | 23 ± 0.2 (S) | 21 ± 0.3 (S) | 23 ± 0.2 (S) |
| TOB10 | 21.5 ± 0.1 (S) | CIP5 | 20 ± 0.1 (S) | 20.5 ± 0.2 (S) | 30.5 ± 0.1 (S) |
| SXT25 | 20 ± 0.2 (S) | AMC30 | 21 ± 0.2 (S) | 21 ± 0.1 (S) | 20 ± 0.2 (S) |
| FD10 | 23 ± 0.4 (S) | CN15 | 06 ± 00 (R) | 20 ± 0.2 (S) | 21 ± 0.1 (S) |
| FOX30 | 22 ± 0.1 (S) | CAZ30 | 20 ± 0.1 (S) | 23.5 ± 0.1 (S) | 20.5 ± 0.2 (S) |
| RD30 | 25 ± 00 (S) | CRO30 | 21 ± 00 (S) | 22 ± 00 (S) | 24 ± 00 (S) |
| OFX5 | 20 ± 0.1 (S) | CTX30 | 20 ± 0.2 (S) | 21 ± 0.1 (S) | 23 ± 0.2 (S) |
S: sensitive at standard dose, R: resistant, ATB: antibiotics, CRO: Ceftriaxone, TOB: Tobramycin, AML: amoxicillin, FOX: Cefoxitin, C: Chloramphenicol, CT: Colistin, AMC: Amoxicillin + clavulanic acid, CIP: Ciprofloxacin, AK: Amikacin, IPM: Imipenem, CAZ: Ceftazidime, PRL: Piperacillin, SXT: Trimethoprim + sulfamethoxazole, TE: Tetracycline, CN: Cefalexin, MEM: Meropenem, TIM: Ticarcillin + clavulanic acid, OFX: Ofloxacin, VA: Vancomycin, MY: Lincomycin, FD: Fusidic acid, RD: Rifampicin, CTX: Cefotaxime. Antibiotic disc load was in µg.
Antibacterial activity of T. zygis and T. willdenowii EOs.
| Essential Oils Concentration Tested (µL/mL) | Essential Oils Inhibition Diameter (mm) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| 2 | 75 ± 00 *** | 33 ± 0.2 *** | 54 ± 00 *** | 15 ± 00 ns | 20 ± 00 * | 06 ± 00 ns | 71.5 ± 0.1 *** | 30 ± 00 ** | 60.1 ± 0.1 *** | 14 ± 00 ns | 6 ± 00 ns | 6 ± 00 ns |
| 4 | 84 ± 0.2 *** | 33.8 ± 0.1 *** | 60 ± 00 *** | 16.3 ± 0.1 ns | 24.5 ± 0.3 * | 6 ± 00 ns | 72 ± 00 *** | 35 ± 00 ** | 64.5 ± 0.4 *** | 15.5 ± 1.2 ns | 18 ± 0.1 ns | 6 ± 00 ns |
| 6 | 84 ± 0.1 *** | 38 ± 0.3 *** | 71 ± 00 *** | 18 ± 00 * | 30.1 ± 0.2 ** | 13.5 ± 0.1 ns | 76.3 ± 0.2 *** | 43.6 ± 0.1 *** | 71.3 ± 0.3 *** | 21 ± 00 * | 37.5 ± 0.9 ** | 6 ± 00 ns |
| 8 | 84 ± 0.6 *** | 42 ± 00 *** | 82.2 ± 0.2 *** | 21.4 ± 0.2 * | 50 ± 00 *** | 16 ± 00 ns | 78.1 ± 0.1 *** | 51 ± 00 *** | 77 ± 00 *** | 23 ± 00 * | 40 ± 00 *** | 13 ± 00 ns |
| 10 | 84 ± 0.3 *** | 47.2 ± 0.1 *** | 84 ± 00 *** | 22.1 ± 0.3 * | 52 ± 00 *** | 18.9 ± 1.3* | 80.7 ± 1.4 *** | 56 ± 00 *** | 78.9 ± 0.1 *** | 35 ± 00 * | 48.6 ± 0.4 *** | 15 ± 00 ns |
| 12 | 84 ± 00 *** | 48 ± 00 *** | 84 ± 00 *** | 23 ± 00 * | 57.5 ± 00 *** | 23 ± 00 * | 81 ± 00 *** | 60 ± 00 *** | 82 ± 00 *** | 38 ± 00 * | 51 ± 00 *** | 18 ± 00 * |
| 2(DMSO) | 06 ± 00 | 06 ± 00 | 06 ± 00 *** | 06 ± 00 | 06 ± 00 | 06 ± 00 | 06 ± 00 | 06 ± 00 | 06 ± 00 | 06 ± 00 | 06 ± 00 | 06 ± 00 |
The experiment was performed in minimum 2 replicates with *** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05; ns: not significant compared to control DMSO. Tz: T. zygis; Tw: T. willdenowii.
Determination of MIC and MBC of T. zygis and T. willdenowii EOs.
| Bacteria |
|
| ||
|---|---|---|---|---|
| MIC µL/mL | MBC µL/mL | MIC µL/mL | MBC µL/mL | |
|
| 02 ± 0.002 * | 02 ± 0.001 * | 04 ± 0.006 * | 04 ± 00 ns |
|
| 02 ± 0.0009 * | 02 ± 0.004 * | 04 ± 00 ns | 04 ± 0.01 ** |
| 04 ± 0.003 * | 04 ± 00 ns | 06 ± 00 ns | 06 ± 00 ns | |
|
| 02 ± 0.001 * | 02 ± 0.001 * | 04 ± 0.001 * | 04 ± 0.012 ** |
|
| 02 ± 0.007 * | 02 ± 00 ns | 06 ± 0.008* | 06 ± 0.005 * |
|
| 06 ± 0.0001 * | 06 ± 0.0003 * | 10 ± 00 ns | 10 ± 00 ns |
The experiment was performed in minimum 2 replicates with ** p ≤ 0.01, * p ≤ 0.05; ns: not significant.
Susceptibility test of fungal strains to antifungal.
| Fungal Species | Antifungal: Fluconazole V = 20 µL |
|---|---|
|
| S |
|
| S |
| R | |
|
| R |
|
| R |
Effect of the EO on the growth of yeasts and molds.
| Species | C = 20 µL/mL | ||||
|---|---|---|---|---|---|
| Volatile Oil Inhibition Diameter (mm) | |||||
|
|
|
|
| ||
|
| 40 ± 0.3 * | 29 ± 0.5 ns | 27 ± 1.2 ns | 18 ± 1.3 ns | 40 ± 2.1 ** |
|
| 17 ± 0.1 ns | 19 ± 1.1 ns | 23 ± 0.1 ns | 12 ± 00 ns | 22 ± 00 * |
|
| 24.7 ± 0.1 | 23.7 ± 0.2 | 24 ± 0.6 | 16.3 ± 0.3 | 13.7 ± 02 |
The experiments were performed in a minimum of 2 replicates with ** p ≤ 0.01, * p ≤ 0.05; ns: not significant compared to fluconazole.
Figure 5Antifungal activity of the essential oil of T. willdenowii tested on C. albicans (L13), C. glabrata (L14), Candida spp. (L15), F. solani (H13), and A. fischeri (G2).
MIC and MFC values of T. zygis and T. willdenowii essential oils.
| Fungal |
|
| ||||
|---|---|---|---|---|---|---|
| MIC µL/mL | MFC µL/mL | MFC/MIC | MFC µL/mL | MFC µL/mL | MFC/MIC | |
|
| 20 ± 0.001 * | 20 ± 0.0009 * | 1 | 30 ± 00 ns | 30 ± 00 ns | 1 |
|
| 20 ± 0.015 ** | 20 ± 0.0001 * | 1 | 20 ± 0.0009 * | 20 ± 00 ns | 1 |
| 20 ± 00 ns | 20 ± 00 ns | 1 | 20 ± 0.002 * | 20 ± 0.007 * | 1 | |
|
| 30 ± 00 ns | 30 ± 0.0002 * | 1 | 30 ± 00 ns | 30 ± 00 ns | 1 |
|
| 20 ± 0.014 ** | 20 ± 00 ns | 1 | 20 ± 00 ns | 20 ± 00 ns | 1 |
The experiment was performed in minimum 2 replicates with ** p ≤ 0.01, * p ≤ 0.05; ns: not significant.
Figure 6(A) Thymus zygis L. and (B) Thymus willdenowii Boiss.
Figure 7Determination of the Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC) of essential oils. In this example the MIC is C4 where the strains are alive but inhibited from growth in the tube and the MBC or MFC is C5 where the strains are totally killed by the EOs.